Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma

American Journal of Clinical Pathology

Volumn 108, Issue 4, 1997, Pages 464-473

  Fanburg, Julie C ^a   Rosenberg, Andrew E ^b   Weaver, Donald L ^c   Leslie, Kevin O ^c   Mann, Kenneth G ^c   Taatjes, Douglas J ^c   Tracy, Russell P ^c  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Immunohistochemistry; Monoclonal antibodies; Osteocalcin bone G1a protein; Osteonectin; Osteosarcoma

Indexed keywords

COLLAGEN; MONOCLONAL ANTIBODY; OSTEOCALCIN; OSTEONECTIN;

ARTICLE; BONE TUMOR; CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOMA; MELANOMA; OSTEOSARCOMA; PRIORITY JOURNAL;

EID: 0030821118     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.4.464     Document Type: Article

References (10)

1. Huvos A. Bone Tumors. Philadelphia, Pa: WB Saunders, 1991:85-155.
2. Bacci G, Picci P, Ferrari S, Sangiorgi L, Zanone A, Brach del Prever A. Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Eur J Cancer. 1994;30A:620-626.
3. Meyers P, Heller G, Vlamis V. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering. Cancer Treat Res. 1993;62:309-322.
4. Ornadel D, Souhami R, Whelan J, et al. Doxorubicin and cisplatin with granulocyte colony stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup. J Clin Oncol. 1994;12:1842-1848.
5. Picci P, Ferrari S, Bacci G, Gherlinzoni F. Treatment recommendations for osteosarcoma and adult soft tissue sarcomas. Drugs. 1994;47:82-92.
6. Pignatti G, Bacci G, Picci P, et al. Telangiectatic osteogenic sarcoma of the extremities: results in 17 patients treated with neoadjuvant chemotherapy. Clin Orthop. 1991;270:99-106.
7. Rosen G, Caparros B, Huvos A, et al. Preoperative chemotherapy for osteogenic sarcoma. Cancer. 1982;49:1221-1230.
8. Winkler K, Bielack S, Delling G, Jurgens H, Kotz R, Salzer-Kuntschik M. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS). Cancer Treat Res. 1993;62:269-277.
9. Stenner D, Romberg R, Tracy R, Katzmann J, Riggs B, Mann K. Monoclonal antibodies to native non-collagenous bone-specific proteins. Proc Natl Acad Sci U S A. 1984;81:2868-2872.
10. Carlson C, Tulli H, Jayo M, et al. Immunolocalization of non-collagenous bone matrix proteins in lumbar vertebrae from intact and surgically menopausal cynomolgus monkeys. J Bone Miner Res. 1993;8:71-81.